echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Benxi biological hepatitis B and AIDS test box have been registered. Two products can be put into production this month

    Benxi biological hepatitis B and AIDS test box have been registered. Two products can be put into production this month

    • Last Update: 2020-04-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    On the evening of December 13, Northeast Pharmaceutical released a notice that the hepatitis B virus test kit and HIV test kit developed by Benxi biology, the holding subsidiary of the company, recently obtained the registration of medical devices, and the company's layout in biopharmaceutical field has finally achieved initial results According to the data, Benxi biology was founded in February 2010, and the company holds 75% of its equity The company mainly develops, produces and sells clinical diagnosis and gene detection reagents, and develops, develops and produces infectious disease diagnosis, virus load measurement and blood screening reagents At that time, the main layout of the company was chemical APIs In the overall downturn of VC's main business, the company had to find other growth channels According to the company, the hepatitis B (HBV) nucleic acid (DNA) detection kit (fluorescent probe method) registered for medical devices has the advantages of high sensitivity, small sample usage, strong anti-interference ability and accurate judgment HIV test kit is the only one that can cover 9 HIV-1 gene subtypes in China, reducing the rate of missed HIV test It has the advantages of high detection sensitivity, less sample usage, simple operation, strong anti-interference ability and accurate judgment Northeast Pharmaceutical said that at present, Benxi biology has the production conditions, and the industrialization production can be implemented after obtaining the above two product registration approval documents It is expected that after 1-2 years of market cultivation period, with the continuous R & D and production of new biological products in Benxi, new business segments of biological medicine can be added for the company, opening up the space for medium and long-term profit growth of the company Reporters learned that the two products can be put into production and launched this month.
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.